Interim analyses are common in medical device trials for a variety of reasons. Just having a look is fine, but if the outcome of the analysis could change the conduct of the trial, for example by early stopping for superiority, futility or safety, then there is a problem. This is where alpha spending becomes important.
To understand this let’s start by reviewing s...